North America Addictions Therapeutics Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Addictions Therapeutics Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Addictions Therapeutics Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Addictions Therapeutics Market Regional Analysis

6.2 North America Addictions Therapeutics Market Revenue 2017-2027 (US$ Million)

6.3 North America Addictions Therapeutics Market Forecast Analysis

7. North America Addictions Therapeutics Market Analysis – by Treatment Type

7.1 Nicotine Addiction Treatment

7.1.1 Overview
7.1.2 Nicotine Addiction Treatment: North America Addictions Therapeutics Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.2 Alcohol Addiction Treatment

7.2.1 Overview
7.2.2 Alcohol Addiction Treatment: North America Addictions Therapeutics Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.3 Opioid Addiction Treatment

7.3.1 Overview
7.3.2 Opioid Addiction Treatment: North America Addictions Therapeutics Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.4 Other Substance Addiction Treatment

7.4.1 Overview
7.4.2 Other Substance Addiction Treatment: North America Addictions Therapeutics Market – Revenue and Forecast, 2017-2027 (US$ Million)

8. North America Addictions Therapeutics Market Analysis – by Drug Type

8.1 Varenicline

8.1.1 Overview
8.1.2 Varenicline: North America Addictions Therapeutics Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.2 Bupropion

8.2.1 Overview
8.2.2 Bupropion: North America Addictions Therapeutics Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.3 Nicotine Replacement Products

8.3.1 Overview
8.3.2 Nicotine Replacement Products: North America Addictions Therapeutics Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.4 Buprenorphine

8.4.1 Overview
8.4.2 Buprenorphine: North America Addictions Therapeutics Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.5 Naltrexone

8.5.1 Overview
8.5.2 Naltrexone: North America Addictions Therapeutics Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.6 Disulfiram

8.6.1 Overview
8.6.2 Disulfiram: North America Addictions Therapeutics Market – Revenue and Forecast, 2017-2027 (US$ Million)

9. North America Addictions Therapeutics Market Analysis – by Treatment Center

9.1 Outpatient Treatment Center

9.1.1 Overview
9.1.2 Outpatient Treatment Center: North America Addictions Therapeutics Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.2 Residential Treatment Center

9.2.1 Overview
9.2.2 Residential Treatment Center: North America Addictions Therapeutics Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.3 Inpatient Treatment Center

9.3.1 Overview
9.3.2 Inpatient Treatment Center: North America Addictions Therapeutics Market – Revenue and Forecast, 2017-2027 (US$ Million)

10. North America Addictions Therapeutics Market Analysis – by Distribution Channel

10.1 Hospitals

10.1.1 Overview
10.1.2 Hospitals: North America Addictions Therapeutics Market – Revenue and Forecast, 2017-2027 (US$ Million)

10.2 Medical Stores

10.2.1 Overview
10.2.2 Medical Stores: North America Addictions Therapeutics Market – Revenue and Forecast, 2017-2027 (US$ Million)

11. North America Addictions Therapeutics Market – North America Analysis

11.1 Overview

11.2 North America

11.2.1 North America Addictions Therapeutics Market Breakdown, by Key Country, 2020 and 2027 (%)
11.2.1.1 North America Addictions Therapeutics Market – Revenue and Forecast Analysis – by Country
11.2.1.1 US: North America Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.1.1 US: North America Addictions Therapeutics Market Breakdown, by Treatment Type
11.2.1.1.2 US: North America Addictions Therapeutics Market Breakdown, by Drug Type
11.2.1.1.3 US: North America Addictions Therapeutics Market Breakdown, by Treatment Center
11.2.1.1.4 US: North America Addictions Therapeutics Market Breakdown, by Distribution Channel

11.2.1.2 Canada: North America Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.2.1 Canada: North America Addictions Therapeutics Market Breakdown, by Treatment Type
11.2.1.2.2 Canada: North America Addictions Therapeutics Market Breakdown, by Drug Type
11.2.1.2.3 Canada: North America Addictions Therapeutics Market Breakdown, by Treatment Center
11.2.1.2.4 Canada: North America Addictions Therapeutics Market Breakdown, by Distribution Channel

11.2.1.3 Mexico : North America Addictions Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.3.1 Mexico : North America Addictions Therapeutics Market Breakdown, by Treatment Type
11.2.1.3.2 Mexico : North America Addictions Therapeutics Market Breakdown, by Drug Type
11.2.1.3.3 Mexico : North America Addictions Therapeutics Market Breakdown, by Treatment Center
11.2.1.3.4 Mexico : North America Addictions Therapeutics Market Breakdown, by Distribution Channel

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Indivior PLC

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Pfizer Inc

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 GlaxoSmithKline plc

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Bausch Health Companies Inc

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Cipla Inc.

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Orexo AB

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 PurduePharma L.P

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Alvogen

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Camurus AB

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Hikma Pharmaceuticals PLC

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

North America Addictions Therapeutics Market